glucagon-like peptide-1 analog (Arisaph)

N/A

Report date: 2025/03/20 14:53:47

Base Information

Drug Nameglucagon-like peptide-1 analog (Arisaph)
Drug Alias NameGLP-1 analog (Arisaph)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsInsulin release stimulants
TargetsGlucagon-like peptide 1 receptorInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArisaph Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesArisaph Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A